API | pipenzolate bromide

pipenzolate bromide Report issue

Small molecule Experimental

ChEMBL Drug Central KEGG MeSH PubChem

Active Ingredient History

Pipenzolate bromide (JB-323), an anticholinergic agent, which binds to muscarinic acetylcholine receptors as an antagonist. Pipenzolate bromide was studied as an antispasmodic agent, and to treat peptic ulcer. ^NCATS

Chemistry

SMILES: CC[N+]1(C)CCCC(C1)OC(=O)C(O)(c2ccccc2)c3ccccc3
InChIKey: WPUKUEMZZRVAKZ-UHFFFAOYSA-N
Mol. Mass: 354.47
ALogP: 3.09 Partition coefficient
ChEMBL Molecules:

pipenzolate

pipenzolate

pipenzolate bromide

More Chemistry

Pharmacology

Mechanisms of Action: Missing data
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

Indications (2)

Approved Indications (1)

Peptic Ulcer

Experimental Indications - Clinical Trial Phases 1-4 (1)

Spasm ()

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue